메뉴 건너뛰기




Volumn 124, Issue 4, 2009, Pages

Analysis of behavior-related adverse experiences in clinical trials of montelukast

Author keywords

adverse experiences; allergic rhinitis; asthma; behavior; clinical trial; Montelukast; placebo; psychiatric

Indexed keywords

MONTELUKAST; PLACEBO; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; QUINOLINE DERIVATIVE;

EID: 70449704180     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.08.011     Document Type: Article
Times cited : (79)

References (37)
  • 1
    • 71749105762 scopus 로고    scopus 로고
    • SINGULAIR (montelukast sodium) prescribing information [package insert, Whitehouse Station NJ, Merck & Co, Inc, 2009
    • SINGULAIR (montelukast sodium) prescribing information [package insert]. Whitehouse Station (NJ): Merck & Co, Inc., 2009.
  • 3
  • 4
    • 57349157753 scopus 로고    scopus 로고
    • The asthma/mental health nexus in a population-based sample of the United States
    • Chun T.H., Weitzen S.H., and Fritz G.K. The asthma/mental health nexus in a population-based sample of the United States. Chest 134 (2008) 1176-1182
    • (2008) Chest , vol.134 , pp. 1176-1182
    • Chun, T.H.1    Weitzen, S.H.2    Fritz, G.K.3
  • 5
    • 57049127774 scopus 로고    scopus 로고
    • Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System
    • Strine T.W., Mokdad A.H., Balluz L.S., Gonzalez O., Crider R., Berry J.T., et al. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatric Services 59 (2008) 1383-1390
    • (2008) Psychiatric Services , vol.59 , pp. 1383-1390
    • Strine, T.W.1    Mokdad, A.H.2    Balluz, L.S.3    Gonzalez, O.4    Crider, R.5    Berry, J.T.6
  • 6
    • 34247229666 scopus 로고    scopus 로고
    • Developmental and behavioral comorbidities of asthma in children
    • Blackman J.A., and Gurka M.J. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 28 (2007) 92-99
    • (2007) J Dev Behav Pediatr , vol.28 , pp. 92-99
    • Blackman, J.A.1    Gurka, M.J.2
  • 7
    • 35248851253 scopus 로고    scopus 로고
    • The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls
    • Katon W., Lozano P., Russo J., McCauley E., Richardson L., and Bush T. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 41 (2007) 455-463
    • (2007) J Adolesc Health , vol.41 , pp. 455-463
    • Katon, W.1    Lozano, P.2    Russo, J.3    McCauley, E.4    Richardson, L.5    Bush, T.6
  • 8
    • 70249116131 scopus 로고    scopus 로고
    • and, SINGULAIR, March 27, 2008. Available at:, Accessed August 10, 2009
    • US Food and Drug Administration. Early communication about an ongoing safety review of montelukast (SINGULAIR), March 27, 2008. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm095019.htm. Accessed August 10, 2009.
    • Early communication about an ongoing safety review of montelukast
    • Food, U.S.1
  • 11
    • 0000936448 scopus 로고
    • The analysis of several 2x2 contingency tables
    • Zelen M. The analysis of several 2x2 contingency tables. Biometrika 58 (1971) 129-137
    • (1971) Biometrika , vol.58 , pp. 129-137
    • Zelen, M.1
  • 12
    • 71749103730 scopus 로고    scopus 로고
    • Center for Drug Evaluation and Research (CDER)
    • and, March, Available at:, Accessed August 10, 2009
    • US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance: drug safety information-FDA's communication to the public, March 2007. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064993.htm. Accessed August 10, 2009.
    • (2007) Guidance: Drug safety information-FDA's communication to the public
    • Food, U.S.1
  • 13
    • 38149028546 scopus 로고    scopus 로고
    • Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens
    • Postolache T.T., Lapidus M., Sander E.R., Langenberg P., Hamilton R.G., Soriano J.J., et al. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. Sci World J 17 (2007) 1968-1977
    • (2007) Sci World J , vol.17 , pp. 1968-1977
    • Postolache, T.T.1    Lapidus, M.2    Sander, E.R.3    Langenberg, P.4    Hamilton, R.G.5    Soriano, J.J.6
  • 14
    • 0025736639 scopus 로고
    • Depression and allergies: survey of a nonclinical population
    • Bell I., Jasnoski M., Kagan J., and King D. Depression and allergies: survey of a nonclinical population. Psychother Psychosom 55 (1991) 24-31
    • (1991) Psychother Psychosom , vol.55 , pp. 24-31
    • Bell, I.1    Jasnoski, M.2    Kagan, J.3    King, D.4
  • 15
    • 0032755767 scopus 로고    scopus 로고
    • Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20-39 years in the United States
    • Hurwitz E.L., and Morgenstern H. Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20-39 years in the United States. Am J Epidemiol 150 (1999) 1107-1116
    • (1999) Am J Epidemiol , vol.150 , pp. 1107-1116
    • Hurwitz, E.L.1    Morgenstern, H.2
  • 16
    • 0037102001 scopus 로고    scopus 로고
    • Association between skin test diagnosed atopy and professionally diagnosed depression: a Northern Finland 1966 Birth Cohort study
    • Timonen M., Jokelainen J., Silvennoinen-Kassinen S., Herva A., Zitting P., Xu B., et al. Association between skin test diagnosed atopy and professionally diagnosed depression: a Northern Finland 1966 Birth Cohort study. Biol Psychiatry 52 (2002) 349-355
    • (2002) Biol Psychiatry , vol.52 , pp. 349-355
    • Timonen, M.1    Jokelainen, J.2    Silvennoinen-Kassinen, S.3    Herva, A.4    Zitting, P.5    Xu, B.6
  • 18
    • 0037841747 scopus 로고    scopus 로고
    • Presence of atopy in first-degree relatives as a predictor of a female proband's depression: Results from the Northern Finland 1966 Birth Cohort
    • Timonen M., Jokelainen J., Herva A., Zitting P., Meyer-Rochow V.P., and Räsänen P. Presence of atopy in first-degree relatives as a predictor of a female proband's depression: Results from the Northern Finland 1966 Birth Cohort. J Allergy Clin Immunol 111 (2003) 1249-1254
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 1249-1254
    • Timonen, M.1    Jokelainen, J.2    Herva, A.3    Zitting, P.4    Meyer-Rochow, V.P.5    Räsänen, P.6
  • 19
    • 33744487383 scopus 로고    scopus 로고
    • Major depression and allergy: does neuroticism explain the relationship?
    • Goodwin R.D., Castro M., and Kovacs M. Major depression and allergy: does neuroticism explain the relationship?. Psychosom Med 68 (2006) 94-98
    • (2006) Psychosom Med , vol.68 , pp. 94-98
    • Goodwin, R.D.1    Castro, M.2    Kovacs, M.3
  • 20
    • 71749087802 scopus 로고    scopus 로고
    • ADVAIR® DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) prescribing information [package insert, Research Triangle Park NC, GlaxoSmithKline, 2009
    • ADVAIR® DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) prescribing information [package insert]. Research Triangle Park (NC): GlaxoSmithKline, 2009.
  • 21
    • 71749099450 scopus 로고    scopus 로고
    • FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) prescribing information. Research Triangle Park (NC): GlaxoSmithKline, 2008.
    • FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) prescribing information. Research Triangle Park (NC): GlaxoSmithKline, 2008.
  • 22
    • 71749120022 scopus 로고    scopus 로고
    • PULMICORT FLEXHALER™ (budesonide) Aerosol, Powder prescribing information. Wilmington (DE): AstraZeneca LP, 2008.
    • PULMICORT FLEXHALER™ (budesonide) Aerosol, Powder prescribing information. Wilmington (DE): AstraZeneca LP, 2008.
  • 23
    • 22044450186 scopus 로고    scopus 로고
    • Public-released version of the Adverse Event Reporting System (AERS) database
    • [letter] author reply 357-9
    • Strauss A., Gould A.L., Nelsen L.M., Wiholm B.E., and Jones J.K. Public-released version of the Adverse Event Reporting System (AERS) database. [letter]. Clin Ther 27 (2005) 355-357 author reply 357-9
    • (2005) Clin Ther , vol.27 , pp. 355-357
    • Strauss, A.1    Gould, A.L.2    Nelsen, L.M.3    Wiholm, B.E.4    Jones, J.K.5
  • 24
    • 71749096662 scopus 로고    scopus 로고
    • Quarter, Available at:, Accessed August 10, 2009
    • The Institute for Safe Medication Practices. QuarterWatch: 2008 Quarter 2. Available at: http://www.ismp.org/QuarterWatch/200901.pdf. Accessed August 10, 2009.
    • (2008) QuarterWatch , pp. 2
  • 26
    • 42049112159 scopus 로고    scopus 로고
    • Individual case safety reports in children in commonly used drug groups-signal detection
    • Brunlöf G., Tukukino C., and Wallerstedt S.M. Individual case safety reports in children in commonly used drug groups-signal detection. BMC Clin Pharmacol 8 (2008) 1
    • (2008) BMC Clin Pharmacol , vol.8 , pp. 1
    • Brunlöf, G.1    Tukukino, C.2    Wallerstedt, S.M.3
  • 27
    • 53049100875 scopus 로고    scopus 로고
    • Montelukast and emotional well-being as a marker for depression: results from three randomized, double-masked clinical trials
    • Holbrook J.T., and Harik-Khan R. Montelukast and emotional well-being as a marker for depression: results from three randomized, double-masked clinical trials. J Allergy Clin Immunol 122 (2008) 828-829
    • (2008) J Allergy Clin Immunol , vol.122 , pp. 828-829
    • Holbrook, J.T.1    Harik-Khan, R.2
  • 28
    • 65649108414 scopus 로고    scopus 로고
    • A review of the pathways underlying the association between asthma and major depressive disorder
    • Van Lieshout R.J., Bienenstock J., and MacQueen G.M. A review of the pathways underlying the association between asthma and major depressive disorder. Psychosom Med 71 (2009) 187-195
    • (2009) Psychosom Med , vol.71 , pp. 187-195
    • Van Lieshout, R.J.1    Bienenstock, J.2    MacQueen, G.M.3
  • 29
    • 0033600291 scopus 로고    scopus 로고
    • Characterization of the human cysteinyl leukotriene CysLT1 receptor
    • Lynch K.R., O'Neill G.P., Liu Q., Im D.-S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-883
    • (1999) Nature , vol.399 , pp. 789-883
    • Lynch, K.R.1    O'Neill, G.P.2    Liu, Q.3    Im, D.-S.4    Sawyer, N.5    Metters, K.M.6
  • 30
    • 0029063884 scopus 로고
    • Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist [published erratum in: Can J Physiol Pharmacol 1995;73:747]
    • Jones T.R., Labelle M., Belley M., Champion E., Charette L., Evans J., et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist [published erratum in: Can J Physiol Pharmacol 1995;73:747]. Can J Physiol Pharmacol 73 (1995) 191-201
    • (1995) Can J Physiol Pharmacol , vol.73 , pp. 191-201
    • Jones, T.R.1    Labelle, M.2    Belley, M.3    Champion, E.4    Charette, L.5    Evans, J.6
  • 31
    • 33646795009 scopus 로고    scopus 로고
    • Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats
    • Fang S.H., Wei E.Q., Zhou Y., Wang M.L., Zhang W.P., Yu G.L., et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience 140 (2006) 969-979
    • (2006) Neuroscience , vol.140 , pp. 969-979
    • Fang, S.H.1    Wei, E.Q.2    Zhou, Y.3    Wang, M.L.4    Zhang, W.P.5    Yu, G.L.6
  • 32
    • 33749323854 scopus 로고    scopus 로고
    • The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
    • Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25 (2006) 4615-4627
    • (2006) EMBO J , vol.25 , pp. 4615-4627
    • Ciana, P.1    Fumagalli, M.2    Trincavelli, M.L.3    Verderio, C.4    Rosa, P.5    Lecca, D.6
  • 33
    • 56349145808 scopus 로고    scopus 로고
    • The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair
    • e3579
    • Lecca D., Trincavelli M.L., Gelosa P., Sironi L., Ciana P., Fumagalli M., et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS ONE 3 (2008) e3579
    • (2008) PLoS ONE , vol.3
    • Lecca, D.1    Trincavelli, M.L.2    Gelosa, P.3    Sironi, L.4    Ciana, P.5    Fumagalli, M.6
  • 35
    • 0036032974 scopus 로고    scopus 로고
    • 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior
    • Uz T., Dimitrijevic N., Tueting P., and Manev H. 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor Neurol Neurosci 20 (2002) 15-20
    • (2002) Restor Neurol Neurosci , vol.20 , pp. 15-20
    • Uz, T.1    Dimitrijevic, N.2    Tueting, P.3    Manev, H.4
  • 36
    • 41949100044 scopus 로고    scopus 로고
    • Effects of MK-866, a 5-liopoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
    • Uz T., Dimitrijevic N., Imbesi M., Manev H., and Manev R. Effects of MK-866, a 5-liopoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci Lett 436 (2008) 269-272
    • (2008) Neurosci Lett , vol.436 , pp. 269-272
    • Uz, T.1    Dimitrijevic, N.2    Imbesi, M.3    Manev, H.4    Manev, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.